Retatrutide, tirzepatide, and semaglutide are often searched together. A research documentation comparison should focus on classification terms and records, not on personal use, dosing, or outcome claims.
Comparison framework
Use the same documentation framework for each compound: product identity, SKU, batch or lot number, purity or assay value, method labels, and COA/spec availability.
Classification labels
- Semaglutide is commonly associated with GLP-1 terminology.
- Tirzepatide is commonly associated with GLP-1/GIP terminology.
- Retatrutide is commonly associated with multi-receptor incretin-pathway terminology.
COA/spec comparison
When reviewing documentation, compare like-for-like fields. A purity result should be read with its method label and acceptance criteria. A batch number should match the purchased or requested record. A product name should match the SKU or catalog listing.
Buyer checklist
- Confirm exact product name and SKU.
- Record batch or lot number when available.
- Review purity, assay, and identity fields.
- Request missing COA/spec documentation through the supplier.